Sugapriya Dhanasekaran | Cancer Science | Best Academic Researcher Award

Best Academic Researcher Award

Sugapriya Dhanasekaran
Manipal University College Malaysia

Sugapriya Dhanasekaran is an academic researcher affiliated with Manipal University College Malaysia, Malaysia. Her research profile is associated with the subject area of Cancer Science. This academic recognition article presents her institutional affiliation, bibliometric information, research-related publications supplied for the profile, and suitability for consideration for the Best Academic Researcher Award at the International Research Awards on Oncology and Cancer Research.

Sugapriya Dhanasekaran
Affiliation Manipal University College Malaysia
Country Malaysia
Scopus ID 55536226300
Documents 53
Citations 920
h-index 18
Subject Area Cancer Science
Event International Research Awards on Oncology and Cancer Research
ORCID 0000-0002-0905-7906

Abstract

Sugapriya Dhanasekaran is affiliated with Manipal University College Malaysia and is associated with the academic subject area of Cancer Science. Her supplied bibliometric profile reports 53 documents, 920 citations, and an h-index of 18. These indicators provide quantitative information about research productivity and citation activity. The publication records supplied alongside the profile include studies involving biomaterials, hydrogel polymers, clinical treatment procedures, laser applications, and nanocrystalline materials. However, the supplied publication records contain contributor names that do not identify Sugapriya Dhanasekaran as an author.[1]

Keywords

  • Sugapriya Dhanasekaran
  • Cancer Science
  • Academic Research
  • Research Publications
  • Bibliometric Indicators

Introduction

Academic research contributes to the advancement of scientific knowledge through systematic investigation, publication, collaboration, and dissemination of findings. In biomedical and cancer-related disciplines, research activities can support the understanding of disease mechanisms, therapeutic approaches, clinical procedures, and emerging scientific applications.

Research Profile

The available profile information identifies Sugapriya Dhanasekaran as affiliated with Manipal University College Malaysia. The academic subject area provided for this recognition profile is Cancer Science. Her reported Scopus author identifier is 55536226300, which can be used to locate and verify the associated bibliographic record through Elsevier’s Scopus platform.[1]

Research Contributions

The publication information provided for this article covers several scientific and biomedical topics, including hydrogel-based polymers, clinical treatment procedures, laser-assisted therapeutic applications, and nanocrystalline materials. These topics illustrate the multidisciplinary nature of biomedical research, where materials science, clinical medicine, and technological development can intersect.

Publications

The following bibliographic records were included in the supplied material. They are presented for reference and bibliographic transparency. The contributor information does not establish that Sugapriya Dhanasekaran authored these publications. The records should be cross-checked against the researcher’s Scopus profile before being included in an attributed publication list.

  1. Hydrogel tissue expanders for stomatology. Part I. Methacrylate-based polymers.
  2. Infantile hemangiomas. Current treatment procedures | Infantilní hemangiomas. Současné tělečné protředky.
  3. Direct and indirect treatment of pain with lasers – Update 2016.

Research Impact

Research impact can be assessed through multiple dimensions, including scholarly publications, citations, research collaboration, methodological contributions, and the relevance of findings to scientific or clinical practice. The supplied profile reports 53 documents, 920 citations, and an h-index of 18 for Sugapriya Dhanasekaran. These indicators suggest a measurable scholarly publication and citation record, subject to confirmation against the current indexed author profile.

Award Suitability

The Best Academic Researcher Award recognizes researchers who demonstrate sustained academic engagement, scholarly productivity, and contributions to their respective research disciplines. The International Research Awards on Oncology and Cancer Research provides a platform for recognizing research activities and academic achievements associated with oncology and related scientific fields.Based on the supplied profile, Sugapriya Dhanasekaran has several bibliometric indicators that may be considered during an academic recognition assessment:

Conclusion

Sugapriya Dhanasekaran is presented in this academic recognition profile as a researcher affiliated with Manipal University College Malaysia, Malaysia, with Cancer Science identified as the relevant subject area. The supplied bibliometric information reports 53 documents, 920 citations, and an h-index of 18. These indicators offer a quantitative perspective on the research profile and provide information relevant to academic recognition.

References

  1. Elsevier. (n.d.). Scopus author details: Sugapriya Dhanasekaran, Author ID 55536226300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55536226300
  2. Hrib, J., Sirc, J., Lesny, P., Hobzova, R., Duskova-Smrckova, M., Michalek, J., & Smucler, R. (2017). Hydrogel tissue expanders for stomatology. Part I. Methacrylate-based polymers. Journal of Materials Science: Materials in Medicine. DOI: 10.1007/s10856-016-5818-y.
    https://www.researchgate.net/profile/Sugapriya-Dhanasekaran-3
  3. Large scale preparation of up-converting YF₃:YbEr nanocrystals with various sizes by solvothermal syntheses using ionic liquid bmimCl. Journal of Fluorine Chemistry. DOI: 10.1016/j.jfluchem.2016.05.015.
    https://doi.org/10.1016/j.jfluchem.2016.05.015
  4. Lippert, J., Šmucler, R., & Vlk, M. (2013). Fractional carbon dioxide laser improves nodular basal cell carcinoma treatment with photodynamic therapy with methyl 5-aminolevulinate. Dermatologic Surgery. DOI: 10.1111/dsu.12242.
    https://doi.org/10.1111/dsu.12242
  5. ORCID. (n.d.). Sugapriya Dhanasekaran researcher identifier.
    https://orcid.org/0000-0002-0905-7906

Prof. Linghua Li | Cancer Science | Best Researcher Award

Prof. Linghua Li | Cancer Science | Best Researcher Award

Guangzhou Eighth People’s Hospital | China

Author Profile

ORCID ID

🌟Linghua Li, Ph.D., M.S., B.S. 🌍

Head Director, Infectious Disease Center
Guangzhou Eighth People’s Hospital, Guangzhou Medical University

👩‍⚕️Biography

Dr. Linghua Li is a distinguished physician and researcher specializing in HIV/AIDS, infectious diseases, and oncology. With over 25 years of clinical experience, she has made significant contributions to understanding and managing infectious diseases, particularly fungal infections and HIV-related complications.

Dr. Li began her academic journey at the Medical School of Peking University, earning a B.S. in Clinical Medicine in 1997. She then pursued advanced studies at Sun Yat-sen University, completing an M.S. in Internal Medicine in 2008 and a Ph.D. in Infectious Diseases in 2011. She further enriched her expertise through visiting scholar positions at UNC-Chapel Hill (2012) and Duke University (2014), focusing on infectious diseases.

As the Head Director of the Infectious Disease Center at Guangzhou Eighth People’s Hospital, Dr. Li oversees clinical trials, patient care, and research initiatives for people living with HIV and at-risk populations. She has been principal investigator (PI) or co-investigator (Co-I) on more than 20 domestic and international research programs. Notable projects include:

  • National Natural Science Foundation of China (Grant No. 81301480): Investigating the mechanism and function of Phospholipase B in the growth and pathogenicity of P. marneffei.
  • Guangdong Natural Science Foundation (Grant No. 10151006002000000): Exploring the role of Phospholipase B in P. marneffei invasion of macrophages in AIDS patients.
  • NIH Fogarty Program: Examining host factors in severe opportunistic complications of AIDS, with a focus on developing targeted prophylactic strategies.

In recent years, Dr. Li has been a Co-PI on groundbreaking HIV PrEP Phase IV clinical trials in Guangzhou, including:

  • ChiCTR2100048981 and NCT04754139: These studies focus on scaling PrEP access for key populations in China. The trial successfully enrolled 1,007 participants by 2023, with 950 already on PrEP, marking it as the largest trial of its kind in China.

Dr. Li’s work emphasizes translational medicine, data-driven public health strategies, and the implementation of novel interventions like PrEP to curb HIV transmission. Her expertise in site coordination, implementation, data collection, and analysis has been pivotal to these efforts.

🧬Key Areas of Expertise

🔬 HIV Prevention and Treatment
🌿 Opportunistic Infections
📊 Clinical Trials and Data Analysis
🧑‍⚕️ Internal and Infectious Diseases

📚Academic Background

  • B.S., Clinical Medicine, Medical School of Peking University (1997)
  • M.S., Internal Medicine, Sun Yat-sen University (2008)
  • Ph.D., Infectious Diseases, Sun Yat-sen University (2011)
  • Visiting Scholar, UNC-Chapel Hill (2012)
  • Visiting Scholar, Duke University (2014)

🔬Research Impact

🌟 Over 20 funded research projects
📄 Numerous publications in infectious disease and public health journals
📚 Active contributor to advancing HIV prevention strategies in China

Dr. Linghua Li remains a leader in the fight against infectious diseases, with a career dedicated to improving global health outcomes. 🌏✨

✨ Conclusion

Dr. Linghua Li’s career exemplifies dedication to advancing the prevention, treatment, and understanding of infectious diseases, particularly HIV/AIDS and associated complications. Through her leadership, innovative research, and clinical expertise, she has significantly impacted global health, especially in developing effective interventions like PrEP for key populations in China. Her contributions to translational medicine and public health continue to pave the way for breakthroughs in managing infectious diseases and improving the lives of those affected worldwide. 🌟🌍

📊🔬NOTABLE PUBLICATION:
  • Utilizing Protein–Peptide Hybrid Microarray for Time-Resolved Diagnosis and Prognosis of COVID-19
    • Authors: Peiyan Zheng, Baolin Liao, Jiao Yang, Hu Cheng, Zhangkai Cheng, Huimin Huang, Wenting Luo, Yiyue Sun, Qiang Zhu, Yi Deng, et al.
    • Journal: Microorganisms
    • Year: 2023